| |
Newsroom /
Health and Fitness
/
Health and Fitness
/
A Series of Reports By EMR provides an In-depth Insight into The Key Developed Antibacterial Market
A Series of Reports By EMR provides an In-depth Insight into The Key Developed Antibacterial Market
EMR’s latest publications provide an exceptional tool to understand the current trends, therapeutic structure, competitive landscape and the outlook for key developed Antibacterial drug markets till 2016
Noida,
UP,
India
(prbd.net)
27/09/2011
In its new series of reports on antibacterial markets, Expert Market Research, one of the world’s leading providers of lifescience market intelligence, analyses the market potential of antibacterial drugs in key developed markets.
EMR’s antibacterial drug market series includes reports on the following countries:
• US Antibacterial Market Report and Forecast: 2011-2016
• Japan Antibacterial Market Report and Forecast: 2011-2016
• Italy Antibacterial Market Report and Forecast: 2011-2016
• Germany Antibacterial Market Report and Forecast: 2011-2016
• Spain Antibacterial Market Report and Forecast: 2011-2016
• France Antibacterial Market Report and Forecast: 2011-2016
• UK Antibacterial Market Report and Forecast: 2011-2016
• Canada Antibacterial Market Report and Forecast: 2011-2016
Each of these reports provide a comprehensive analysis of the current and future market trends in the antibacterial drugs market. These reports also facilitates a deep insight into the current and future epidemiology of bacterial infections and its market structure besides probing into the performance of various therapeutic classes, companies, molecules and brands. These reports can serve as an excellent guide for clients who are in need of an in-depth understanding of the market for antibacterial drugs.
Key Questions Answered in these Reports:
• What is the current and future size of patients suffering from various antibacterial infections?
• What are the current and future incidence rates for various antibacterial infections?
• What has been the historical performance of the antibacterial market and how will it behave in the coming years?
• Who are the leading companies in the antibacterial market and how will they perform in the coming years?
• What has been the historical performance of various antibacterial therapeutic classes and how will they behave in the coming years?
• What are the leading molecules in the antibacterial market and how will they behave in the coming years?
Why should you buy these Reports?
• To gain an in-depth insight into the incidence rates for antibacterial infections
• To have it as a powerful tool for identifying your target patient population.
• To facilitate business decision-making based on historical, current and forecast market data for antibacterial drugs
• To identify potential classes, drugs, partners and competitors so as to develop strategies for market penetration and drug development
• To develop business strategies by looking at companies that have been the biggest winners and losers in the antibacterial market.
• To gain an understanding into future market events and make more informed business decisions.
Research Objectives Achieved in these Reports:
Evaluating the Epidemiology of Bacterial Infections:
Key Aspects Analyzed:
• Current and future incidence of various bacterial infections
• Current and future size of patients suffering from various bacterial infections
Comprehensive Situation Analysis of the Antibacterial Market:
Classes Covered: Oral Cephalosphorins, Injectable Cephalosphorins, Oral Fluoroquinolones, Injectable Fluoroquinolones, Macrolides, Oral Broad Spectrum Penicillins, Injectable Broad Spectrum Penicillins, Penems & Carbapenems, Tetracyclines & Combinations and all other Antibacterial.
Key Aspects Analyzed:
• Historical, current and future market trends
• Historical, current and future performance of various drugs
• Historical, current and future performance of various companies.
• Product portfolio of various companies
• Historical, current and future performance of various therapeutic classes
Methodology & Information Sources:
To prepare this report, material was mined from both primary and secondary data sources. Primary information sources included data provided by pharmaceutical manufacturers, marketing strategists, scientists, doctors and product managers at leading pharmaceutical companies. Secondary data sources include both proprietary and public databases. These included company websites, annual reports, financial reports, 10K’s, government resources, books, magazines, white papers, journals, analyst reports and access to thousands of proprietary databases.
Table of Contents
1. Research Methodology & Definitions
2. Executive Summary
3. Antibacterial Infections: Incidence & Patient Population
3.1 Incidence of Various Antibacterial Infections
3.2 Size of the Patient Pool
4. The Antibacterial Drugs Market Landscape
4.1 Current Trends & Forecast
4.1.1 Current Market Trends
4.1.2 Market Forecast
4.2 Performance of Various Therapeutic Classes
4.2.1 Oral Cephalosphorins
4.2.1.1 Current Market Trends
4.2.1.2 Sales of Various Molecules
4.2.1.3 Sales of Key Companies
4.2.1.4 Sales Forecast
4.2.2 Injectable Cephalosphorins
4.2.2.1 Current Market Trends
4.2.2.2 Sales of Various Molecules
4.2.2.3 Sales of Key Companies
4.2.2.4 Sales Forecast
4.2.3 Oral Fluoroquinolones
4.2.3.1 Current Market Trends
4.2.3.2 Sales of Various Molecules
4.2.3.3 Sales of Key Companies
4.2.3.4 Sales Forecast
4.2.4 Injectable Fluoroquinolones
4.2.4.1 Current Market Trends
4.2.4.2 Sales of Various Molecules
4.2.4.3 Sales of Key Companies
4.2.4.4 Sales Forecast
4.2.5 Macrolides
4.2.5.1 Current Market Trends
4.2.5.2 Sales of Various Molecules
4.2.5.3 Sales of Key Companies
4.2.5.4 Sales Forecast
4.2.6 Oral Broad Spectrum Penicillins
4.2.6.1 Current Market Trends
4.2.6.2 Sales of Various Molecules
4.2.6.3 Sales of Key Companies
4.2.6.4 Sales Forecast
4.2.7 Injectable Broad Spectrum Penicillins
4.2.7.1 Current Market Trends
4.2.7.2 Sales of Various Molecules
4.2.7.3 Sales of Key Companies
4.2.7.4 Sales Forecast
4.2.8 Penems & Carbapenems
4.2.8.1 Current Market Trends
4.2.8.2 Sales of Various Molecules
4.2.8.3 Sales of Key Companies
4.2.8.4 Sales Forecast
4.2.9 Tetracyclines & Combinations
4.3.9.1 Current Market Trends
4.3.9.2 Sales of Various Molecules
4.3.9.3 Sales of Key Companies
4.3.9.4 Sales Forecast
4.3.10 All other Antibacterials
4.3.10.1 Current Market Trends
4.3.10.2 Sales of Various Molecules
4.3.10.3 Sales of Key Companies
4.3.10.4 Sales Forecast
To buy the complete report or to get a free sample:
Call: +91-880-236-2536 (Asia), +1 206 204-1851 (America & Europe)
Email: sales@expertmarketresearch.com
To know more please visit: http://www.expertmarketresearch.com
About
Expert Market Research is one of the world’s leading providers of lifescience market intelligence. Our award winning and trusted portfolio of proprietary business solutions have been supporting some of the world’s leading pharmaceutical companies, biotechnology companies, medical device companies, clinical research organizations, contract manufacturers and hospitals for over 6 years. We have helped organizations in achieving peak performance, maintaining their leadership positions and raising th
|